JP2023545517A5 - - Google Patents
Info
- Publication number
- JP2023545517A5 JP2023545517A5 JP2023523050A JP2023523050A JP2023545517A5 JP 2023545517 A5 JP2023545517 A5 JP 2023545517A5 JP 2023523050 A JP2023523050 A JP 2023523050A JP 2023523050 A JP2023523050 A JP 2023523050A JP 2023545517 A5 JP2023545517 A5 JP 2023545517A5
- Authority
- JP
- Japan
- Prior art keywords
- cdr
- cells
- amino acid
- seq
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063092736P | 2020-10-16 | 2020-10-16 | |
| US63/092,736 | 2020-10-16 | ||
| US202163151483P | 2021-02-19 | 2021-02-19 | |
| US63/151,483 | 2021-02-19 | ||
| PCT/US2021/055302 WO2022082059A1 (en) | 2020-10-16 | 2021-10-15 | Chimeric receptors and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023545517A JP2023545517A (ja) | 2023-10-30 |
| JP2023545517A5 true JP2023545517A5 (https=) | 2024-10-18 |
Family
ID=81209346
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023523050A Pending JP2023545517A (ja) | 2020-10-16 | 2021-10-15 | キメラ受容体およびその使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12611458B2 (https=) |
| EP (1) | EP4228682A4 (https=) |
| JP (1) | JP2023545517A (https=) |
| KR (1) | KR20230109138A (https=) |
| AU (1) | AU2021361993A1 (https=) |
| CA (1) | CA3195817A1 (https=) |
| IL (1) | IL302148A (https=) |
| TW (1) | TWI907544B (https=) |
| WO (1) | WO2022082059A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3247456A1 (en) * | 2022-04-20 | 2023-10-26 | Senti Biosciences, Inc. | DOMAINS OF BINDING TO AN ANTIGEN AND THEIR METHODS OF USE |
| WO2025085867A1 (en) * | 2023-10-20 | 2025-04-24 | A2 Biotherapeutics, Inc. | Compositions and methods for treating blood cancers |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7214786B2 (en) * | 2000-12-14 | 2007-05-08 | Kovalic David K | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
| JP6199054B2 (ja) * | 2013-03-19 | 2017-09-20 | 公益財団法人かずさＤｎａ研究所 | 抗イヌＩｇＥモノクローナル抗体並びに抗イヌＩｇＥモノクローナル抗体の重鎖可変領域及び軽鎖可変領域 |
| US10654926B2 (en) * | 2014-05-02 | 2020-05-19 | Medimmune Limited | P2X4 antibodies and uses thereof |
| WO2017173327A1 (en) * | 2016-03-31 | 2017-10-05 | The Schepens Eye Research Institute, Inc. | Endomucin inhibitor as an anti-angiogenic agent |
| BR112021006100A2 (pt) * | 2018-09-28 | 2021-07-20 | Immpact-Bio Ltd. | métodos para identificação de pares de receptor de antígeno ativador (acar)/receptor de antígeno quimérico inibitório (icar) para uso em terapias de câncer |
| TW202110873A (zh) * | 2019-04-30 | 2021-03-16 | 美商聖堤生物科技股份有限公司 | 嵌合受體及其使用方法 |
| WO2021157601A1 (ja) * | 2020-02-03 | 2021-08-12 | 国立大学法人東海国立大学機構 | がんを有する対象においてがんを処置することに用いるための抗ｍｅｆｌｉｎ抗体、および当該抗体を含む医薬組成物 |
| CN115298209A (zh) * | 2020-02-20 | 2022-11-04 | 森迪生物科学公司 | 抑制性嵌合受体构造体 |
-
2021
- 2021-10-15 KR KR1020237016201A patent/KR20230109138A/ko active Pending
- 2021-10-15 WO PCT/US2021/055302 patent/WO2022082059A1/en not_active Ceased
- 2021-10-15 CA CA3195817A patent/CA3195817A1/en active Pending
- 2021-10-15 EP EP21881235.2A patent/EP4228682A4/en active Pending
- 2021-10-15 IL IL302148A patent/IL302148A/en unknown
- 2021-10-15 JP JP2023523050A patent/JP2023545517A/ja active Pending
- 2021-10-15 AU AU2021361993A patent/AU2021361993A1/en active Pending
- 2021-10-18 TW TW110138533A patent/TWI907544B/zh active
-
2023
- 2023-04-14 US US18/300,981 patent/US12611458B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240342305A1 (en) | Antibody against glypican-3 and application thereof | |
| CA2889681C (en) | Bispecific igg antibodies as t cell engagers | |
| KR102357312B1 (ko) | Ｃｄ20 결합 분자 및 그의 용도 | |
| EP4039705A1 (en) | Antibody targeting bcma, bispecific antibody, and use thereof | |
| WO2020060406A1 (en) | Novel bispecific antibodies for use in the treatment of hematological malignancies | |
| KR20190034588A (ko) | 키메라 항원 수용체 및 pd-1 억제제의 조합 요법 | |
| JP2024516713A5 (https=) | ||
| JP2018533371A5 (https=) | ||
| US20240002544A1 (en) | Cd28 bispecific antibodies for targeted t cell activation | |
| KR20190109574A (ko) | 암 치료를 위한 항-fam19a5 항체의 용도 | |
| JP7646768B2 (ja) | 抗－ヒトプログラム細胞死リガンド－１（ｐｄ－ｌ１）の抗体及びその用途 | |
| CN116323667A (zh) | 结合PSMA和γ-δT细胞受体的抗体 | |
| CN116368154A (zh) | 三特异性结合剂 | |
| CN113454111A (zh) | 抗体配制剂 | |
| JP2023530083A (ja) | Ｈｌａ－ｇ及び別の抗原に対して結合特異性を有する二重特異性免疫細胞エンゲージャー | |
| KR20230074192A (ko) | 인간 cd3 엡실론에 결합하는 신규의 인간 항체 | |
| JP2023545517A5 (https=) | ||
| IL302148A (en) | Chimeric receptors and methods of use thereof | |
| EP4480966A1 (en) | Humanized anti-cd28 antibody and bispecific antibody thereof with anti-cd40 antibody | |
| CN120152735A (zh) | Adgre2嵌合受体nk细胞组合物和使用方法 | |
| CN116178545B (zh) | 一种抗人pd-l1人源化抗体或其抗原结合片段及其应用 | |
| JP7725066B2 (ja) | ヒト化抗ｐｄ－ｌ１抗体 | |
| KR20230162597A (ko) | 안정적인 다중 특이성 분자 및 그 이용 | |
| JP2023536665A5 (https=) | ||
| JP2025513284A5 (https=) |